These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. The biochemical basis of uremic toxicity. Giordano C Int J Pediatr Nephrol; 1982 Dec; 3(4):239-50. PubMed ID: 6762356 [No Abstract] [Full Text] [Related]
48. [Renal replacement therapy by hemodialysis: an overview]. Jacobs C Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513 [TBL] [Abstract][Full Text] [Related]
49. The fraction b 4-2: isolation, characterization and biological activities with reference to uremic polyneuropathy. Man NK; Cueille G; Faguer P; Boudet J; Pierrat D; Zingraff J; Sausse A; Funck-Brentano JL Adv Exp Med Biol; 1987; 223():135-40. PubMed ID: 3447428 [No Abstract] [Full Text] [Related]
50. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients. Sarnatskaya VV; Yushko LA; Sakhno LA; Nikolaev VG; Nikolaev AV; Grinenko DV; Mikhalovsky SV Artif Cells Blood Substit Immobil Biotechnol; 2007; 35(3):287-308. PubMed ID: 17573628 [TBL] [Abstract][Full Text] [Related]
51. Low flux dialysis? Still a role. Hoenich NA Contrib Nephrol; 2002; (137):189-92. PubMed ID: 12101953 [No Abstract] [Full Text] [Related]
52. Are standards and checklists needed in uremia therapy? Shaldon S; Koch KM Kidney Int Suppl; 1985 Dec; 17():S124-6. PubMed ID: 3867781 [No Abstract] [Full Text] [Related]
53. Treatment of artificial kidney dialysate with cycling adsorber-desorbers. Yoshida F; Okazaki M Ann Biomed Eng; 1974 Dec; 2(4):327-34. PubMed ID: 4458563 [No Abstract] [Full Text] [Related]
54. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients. Popławski A; Myśliwiec M Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345 [No Abstract] [Full Text] [Related]
55. Encephalopathic toxicity: an experimental model of uremia and solute-specific dialysis. Teschan PE; Lipman JJ; Lawrence P; BeBoer D Adv Exp Med Biol; 1987; 223():125-9. PubMed ID: 3447427 [No Abstract] [Full Text] [Related]
56. Replacement of excretory kidney function by high-efficiency hemodiafiltration (HDF) with a peptide-permeable membrane. Wizemann V; Techert F; Brüning S; Birk HW; Mueller K Adv Exp Med Biol; 1987; 223():263-6. PubMed ID: 3447444 [No Abstract] [Full Text] [Related]
57. Uremia is an intoxication. Bergström J Kidney Int Suppl; 1985 Dec; 17():S2-4. PubMed ID: 3867795 [No Abstract] [Full Text] [Related]
58. Liquid membrane system directed toward chronic uremia. Asher WJ; Bovée KC; Frankenfeld JW; Hamilton RW; Henderson LW; Holtzapple PG; Li NN Kidney Int Suppl; 1975 Feb; (3):409-12. PubMed ID: 1057717 [No Abstract] [Full Text] [Related]
59. No difference in nitrogen balance between standard prescriptions of hemodialysis and peritoneal dialysis. Lu Q; Cheng L; Axelsson J; Lindholm B; Wang T Blood Purif; 2008; 26(6):511-7. PubMed ID: 18931478 [TBL] [Abstract][Full Text] [Related]
60. Determinants of uraemic toxin removal. Clark WR; Gao D Nephrol Dial Transplant; 2002; 17 Suppl 3():30-4. PubMed ID: 11912297 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]